110020 — Jeonjin Bio Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩26bn
- KR₩23bn
- KR₩16bn
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 4,162 | 8,922 | 15,306 | 1,334 | 1,692 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 28.8 | 183 | 216 | 1,349 | 2,817 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,808 | 9,987 | 16,158 | 4,756 | 7,767 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 834 | 8,048 | 7,997 | 10,948 | 9,765 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,411 | 18,695 | 24,817 | 17,924 | 17,704 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 656 | 7,343 | 13,979 | 7,947 | 11,213 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,513 | 7,413 | 14,022 | 8,359 | 11,484 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 2,898 | 11,282 | 10,796 | 9,565 | 6,220 |
Total Liabilities & Shareholders' Equity | 6,411 | 18,695 | 24,817 | 17,924 | 17,704 |
Total Common Shares Outstanding |